{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:54:43Z","timestamp":1780098883421,"version":"3.54.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1093\/annonc\/mdh090","type":"journal-article","created":{"date-parts":[[2004,3,3]],"date-time":"2004-03-03T19:13:19Z","timestamp":1078341199000},"page":"504-510","source":"Crossref","is-referenced-by-count":45,"title":["Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cellnon-Hodgkin\u2019s lymphoma: a single institution study"],"prefix":"10.1016","volume":"15","author":[{"given":"K.","family":"Belhadj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-H.","family":"Delfau-Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Elgnaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Beaujean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pautas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Allain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Farcet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Haioun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh090_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1997.15.2.445","article-title":"High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin\u2019s lymphoma","volume":"15","author":"Bierman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0015","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0020","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","article-title":"High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma","volume":"336","author":"Gianni","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh090_bb0025","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.1998.16.8.2796","article-title":"VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin\u2019s lymphoma: results of a prospective randomized trial by the non-Hodgkin\u2019s Lymphoma Cooperative Study Group","volume":"16","author":"Santini","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0030","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","article-title":"Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin\u2019s lymphoma: final analysis of the prospective LNH87-2 protocol\u2014a groupe d\u2019Etude des lymphomes de l\u2019Adulte study","volume":"18","author":"Haioun","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10428199609054834","article-title":"Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells","volume":"23","author":"Yerly-Motta","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh090_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/stem.150297","article-title":"Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems","volume":"15","author":"Paulus","year":"1997","journal-title":"Stem Cells"},{"key":"10.1093\/annonc\/mdh090_bb0045","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1200\/JCO.1998.16.8.2803","article-title":"Autologous stem-cell transplantation for non-Hodgkin\u2019s lymphomas: the role of graft purging and radiotherapy posttransplantation\u2014results of a retrospective analysis on 120 patients autografted in a single institution","volume":"16","author":"Fouillard","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0050","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1701612","article-title":"Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)","volume":"23","author":"Martin-Henao","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdh090_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bmt.1701051","article-title":"Should we purge?","volume":"21","author":"Bensinger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdh090_bb0065","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0070","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0075","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0080","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5858\/2001-125-1246-AOPPEL","article-title":"Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man","volume":"125","author":"Lechapt-Zalcman","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1093\/annonc\/mdh090_bb0085","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh090_bb0095","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM199311253292203","article-title":"Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"329","author":"Solal-Celigny","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh090_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.annonc.a059149","article-title":"Fourteen years of high-dose CHOP (ACVB regimen): preliminary conclusions about the treatment of aggressive-lymphoma patients. Hamilton Fairley Award Lecture, European Society for Medical Oncology Meeting, Lisbon, November 21, 1994","volume":"6","author":"Coiffier","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO;2-H","article-title":"Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)","volume":"50","author":"Armitage","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh090_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.1996.14.1.214","article-title":"Outcome of high-dose therapy and autologous transplantation in non-Hodgkin\u2019s lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest","volume":"14","author":"Sharp","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0115","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1182\/blood.V77.11.2524.2524","article-title":"Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin\u2019s lymphoma","volume":"77","author":"Freedman","year":"1991","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V80.4.1083.1083","article-title":"Bone marrows of non-Hodgkin\u2019s lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion","volume":"80","author":"Gribben","year":"1992","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0125","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","article-title":"High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"100","author":"Ladetto","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0130","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","article-title":"Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma","volume":"83","author":"Haas","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0135","first-page":"223","article-title":"Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization","volume":"16","author":"Tarella","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdh090_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/scd.1.1995.4.171","article-title":"Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor","volume":"4","author":"Chabannon","year":"1995","journal-title":"J Hematother"},{"key":"10.1093\/annonc\/mdh090_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.1998.00960.x","article-title":"Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies","volume":"103","author":"Ketterer","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdh090_bb0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","article-title":"Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion","volume":"96","author":"Magni","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh090_bb0155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","article-title":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and rituximab for autografting in patients with non-Hodgkin\u2019s lymphoma","volume":"109","author":"Voso","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdh090_bb0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh090_bb0170","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.20.5.1288","article-title":"Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival","volume":"20","author":"Howard","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh090_bb0175","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.leu.2402302","article-title":"Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo\/immunotherapy for patients with high-risk non-Hodgkin\u2019s lymphoma","volume":"15","author":"Ladetto","year":"2001","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdh090_bb0180","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1083-8791(00)70028-0","article-title":"Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin\u2019s lymphoma","volume":"6","author":"Flinn","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1093\/annonc\/mdh090_bb0185","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.leu.2401242","article-title":"The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin\u2019s lymphoma","volume":"12","author":"Moos","year":"1998","journal-title":"Leukemia"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/3\/504\/557709\/mdh090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:27:26Z","timestamp":1623716846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419641384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0923753419641384"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh090","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}